Lung cancer drug therapy in Hungary – 3-year experience

Hungary is a world leader in lung cancer deaths, so it is of crucial importance that patients have access to modern treatments. The aim of our analysis was to explore how drug treatments are used in Hungary and how they are compatible with international practice. The inpatient and prescription datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Moldvay, Judit, Rokszin, György, Abonyi-Tóth, Zsolt, Katona, Lajos, Fábián, Katalin, Kovács, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435090/
https://www.ncbi.nlm.nih.gov/pubmed/25999737
http://dx.doi.org/10.2147/OTT.S65794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435090/
https://www.ncbi.nlm.nih.gov/pubmed/25999737
http://dx.doi.org/10.2147/OTT.S65794

Ejemplares similares